Emma F Barry

Emma F Barry

UNVERIFIED PROFILE

Are you Emma F Barry?   Register this Author

Register author
Emma F Barry

Emma F Barry

Publications by authors named "Emma F Barry"

Are you Emma F Barry?   Register this Author

14Publications

318Reads

48Profile Views

The mechanism of GM-CSF inhibition by human GM-CSF auto-antibodies suggests novel therapeutic opportunities.

MAbs 2018 10 12;10(7):1018-1029. Epub 2018 Sep 12.

a St. Vincent's Institute of Medical Research , Australian Cancer Research Foundation Rational Drug Discovery Centre , Fitzroy , Victoria , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/19420862.2018.1494107DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204844PMC
October 2018

14-3-3:Shc scaffolds integrate phosphoserine and phosphotyrosine signaling to regulate phosphatidylinositol 3-kinase activation and cell survival.

J Biol Chem 2009 May 13;284(18):12080-90. Epub 2009 Feb 13.

Cell Growth and Differentiation Laboratory, Division of Human Immunology, Hanson Institute, Institute of Medical and Veterinary Science, Frome Road, Adelaide, South Australia 5000, Australia.

View Article

Download full-text PDF

Source
http://www.jbc.org/lookup/doi/10.1074/jbc.M807637200
Publisher Site
http://dx.doi.org/10.1074/jbc.M807637200DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2673277PMC
May 2009

Fibroblast growth factor receptor 2 phosphorylation on serine 779 couples to 14-3-3 and regulates cell survival and proliferation.

Mol Cell Biol 2008 May 10;28(10):3372-85. Epub 2008 Mar 10.

Division of Human Immunology, Institute of Medical and Veterinary Science, Frome Rd. Adelaide, South Australia, Australia.

View Article

Download full-text PDF

Source
http://mcb.asm.org/content/28/10/3372.full.pdf
Web Search
http://mcb.asm.org/cgi/doi/10.1128/MCB.01837-07
Publisher Site
http://dx.doi.org/10.1128/MCB.01837-07DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2423162PMC
May 2008

The Shc-binding site of the betac subunit of the GM-CSF/IL-3/IL-5 receptors is a negative regulator of hematopoiesis.

Blood 2007 Nov 16;110(10):3582-90. Epub 2007 Jul 16.

Cytokine Receptor Laboratory, Division of Human Immunology, Institute of Medical and Veterinary Science, Hanson Institute, Adelaide, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-01-070391DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2077308PMC
November 2007

Growth factor pleiotropy is controlled by a receptor Tyr/Ser motif that acts as a binary switch.

EMBO J 2006 Feb 26;25(3):479-89. Epub 2006 Jan 26.

Cytokine Receptor Laboratory, Department of Human Immunology, Institute of Medical and Veterinary Science, Hanson Institute, Adelaide, SA, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.emboj.7600948DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1383532PMC
February 2006

The phosphoserine-585-dependent pathway of the GM-CSF/IL-3/IL-5 receptors mediates hematopoietic cell survival through activation of NF-kappaB and induction of bcl-2.

Blood 2004 Feb 14;103(3):820-7. Epub 2003 Aug 14.

Cytokine Receptor Laboratory, Department of Human Immunology, Institute of Medical and Veterinary Science, Frome Rd, Adelaide, South Australia, Australia 5000.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2003-06-1999DOI Listing
February 2004